On-boarding of users to Substance, Product, Organisation and Referentials (SPOR) data services
Human medicines European public assessment report (EPAR): Ivemend, fosaprepitant, Date of authorisation: 11/01/2008, Revision: 27, Status: Authorised
European Medicines Agency Write PMS API implementation Guide
Guidelines Consistency Group
Applications for new human medicines under evaluation: November 2025
Human medicines European public assessment report (EPAR): Erivedge, vismodegib, Date of authorisation: 12/07/2013, Date of refusal: 26/04/2013, Revision: 16, Status: Authorised
Minutes - PDCO minutes of the 9-12 September 2025 meeting
15th industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, from 4 December 2025, 12:30 (CET) to 4 December 2025, 17:30 (CET)
Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 7, Status: Authorised